Patients with chronic kidney disease (CKD) exhibit elevated CD14++CD16+ pro-inflammatory monocytes in bone marrow alongside heightened systemic levels of IL-6, IL-1β, and TNF-α, suggesting persistent innate immune activation (79). This evidence concerns the gene IL1B and chronic kidney disease.